Teachers Advisors LLC purchased a new position in Celcuity Inc (NASDAQ:CELC) during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 7,195 shares of the company’s stock, valued at approximately $207,000. Teachers Advisors LLC owned approximately 0.07% of Celcuity at the end of the most recent quarter.
Several other large investors have also bought and sold shares of CELC. Acadian Asset Management LLC increased its position in Celcuity by 58.3% during the third quarter. Acadian Asset Management LLC now owns 4,797 shares of the company’s stock worth $138,000 after purchasing an additional 1,766 shares during the last quarter. California Public Employees Retirement System acquired a new stake in Celcuity during the second quarter worth about $248,000. Schwab Charles Investment Management Inc. acquired a new stake in Celcuity during the second quarter worth about $271,000. Bank of New York Mellon Corp acquired a new stake in Celcuity during the second quarter worth about $291,000. Finally, Renaissance Technologies LLC acquired a new stake in Celcuity during the third quarter worth about $336,000. 15.12% of the stock is currently owned by hedge funds and other institutional investors.
Several equities research analysts recently issued reports on the stock. Craig Hallum raised their price objective on shares of Celcuity from $30.00 to $35.00 and gave the stock a “buy” rating in a research report on Wednesday, November 14th. HC Wainwright set a $36.00 price objective on shares of Celcuity and gave the stock a “buy” rating in a research report on Monday, November 26th.
Celcuity stock opened at $22.20 on Wednesday. Celcuity Inc has a 12-month low of $13.16 and a 12-month high of $31.00.
Celcuity (NASDAQ:CELC) last released its quarterly earnings data on Tuesday, November 13th. The company reported ($0.15) earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.18) by $0.03. As a group, equities research analysts expect that Celcuity Inc will post -0.76 earnings per share for the current fiscal year.
Celcuity Inc, a cellular analysis company, discovers cancer sub-types and commercializes diagnostic tests to enhance the response rates of cancer patients treated with targeted therapies in the United States. The company is developing CELx tests to diagnose two new sub-types of HER2-negative breast cancer.
Featured Story: SEC Filing
Receive News & Ratings for Celcuity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celcuity and related companies with MarketBeat.com's FREE daily email newsletter.